These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34130870)

  • 1. Heterotopic Ossification Following Direct Anterior Total Hip Arthroplasty With and Without Postoperative Analgesic Nonsteroidal Anti-inflammatories.
    Naylor BH; Iturriaga CR; Bisen YB; Caid MJ; Reinhardt KR
    J Arthroplasty; 2021 Oct; 36(10):3471-3477. PubMed ID: 34130870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach.
    White PB; Ramkumar PN; Meftah M; Ghazi N; Ranawat AS; Ranawat CS
    Orthopedics; 2018 Jan; 41(1):e92-e97. PubMed ID: 29120007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study.
    Oni JK; Pinero JR; Saltzman BM; Jaffe FF
    Hip Int; 2014; 24(3):256-62. PubMed ID: 24474408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Aspirin Administered for Venous Thromboembolism Prophylaxis Reduces the Incidence of Heterotopic Ossification in Total Joint Arthroplasty.
    Van Nest DS; Clarkson S; Chisari E; Sherman MB; Parvizi J
    J Arthroplasty; 2021 May; 36(5):1543-1547. PubMed ID: 33485696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Heterotopic Ossification on Self-Reported Outcomes After Total Hip Arthroplasty Using the Direct Anterior Approach.
    Rüdiger HA; Dittrich M; Robinson J; Mansour T; Schwab T; Stadelmann VA; Leunig M
    J Bone Joint Surg Am; 2020 Nov; 102(Suppl 2):91-98. PubMed ID: 32530877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
    Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
    Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
    Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Celecoxib Administration Is Associated With Decreased Incidence and Severity of Heterotopic Ossification After Hip Resurfacing by Direct Lateral Approach in Male Patients.
    Ng M; Brigati D; Wagner TC; Bigart K; Khlopas A; Sultan AA; Mont MA; Brooks P
    Orthopedics; 2018 Nov; 41(6):e807-e812. PubMed ID: 30222794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of heterotopic ossification in direct anterior vs posterior approach to total hip arthroplasty: a retrospective radiographic review.
    Newman EA; Holst DC; Bracey DN; Russell GB; Lang JE
    Int Orthop; 2016 Sep; 40(9):1967-73. PubMed ID: 26611728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.
    Barbato M; D'Angelo E; Di Loreto G; Menna A; Di Francesco A; Salini V; Zoppi U; Cavasinni L; La Floresta P; Romanò CL
    J Orthop Traumatol; 2012 Jun; 13(2):63-7. PubMed ID: 22358779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion.
    Migliorini F; Asparago G; Oliva F; Cuozzo F; Maffulli N
    Expert Opin Pharmacother; 2022 Jul; 23(10):1195-1203. PubMed ID: 35698796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis.
    Migliorini F; Trivellas A; Eschweiler J; Driessen A; Tingart M; Maffulli N
    Calcif Tissue Int; 2021 Feb; 108(2):196-206. PubMed ID: 33044630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib and heterotopic bone formation after total hip arthroplasty.
    Lavernia CJ; Contreras JS; Villa JM; Rossi MD
    J Arthroplasty; 2014 Feb; 29(2):390-2. PubMed ID: 23927909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.
    Koelbl O; Seufert J; Pohl F; Tauscher A; Lehmann H; Springorum HW; Flentje M
    Strahlenther Onkol; 2003 Nov; 179(11):767-73. PubMed ID: 14605747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
    Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
    Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.
    Kölbl O; Knelles D; Barthel T; Raunecker F; Flentje M; Eulert J
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):397-401. PubMed ID: 9788422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis.
    Joice M; Vasileiadis GI; Amanatullah DF
    Bone Joint J; 2018 Jul; 100-B(7):915-922. PubMed ID: 29954195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
    Haffer H; Müller M; Ascherl R; Perka C; Winkler T
    Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin decreases heterotopic ossification after hip resurfacing.
    Nunley RM; Zhu J; Clohisy JC; Barrack RL
    Clin Orthop Relat Res; 2011 Jun; 469(6):1614-20. PubMed ID: 21409458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
    Pohl F; Seufert J; Tauscher A; Lehmann H; Springorum HW; Flentje M; Koelbl O
    Strahlenther Onkol; 2005 Aug; 181(8):529-33. PubMed ID: 16044221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.